JAK2 and lung cancer: ,27 The results of Zhang et al27 suggested that the overexpression of miR-4443 promoted the resistance to epirubicin-based chemotherapy of non–small-cell lung cancer cells via the activation of the Janus kinase 2 (JAK2)/STAT3 pathway.